Northern Trust’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.02M | Buy |
1,162,092
+19,164
| +2% | +$66.3K | ﹤0.01% | 2581 |
|
2025
Q1 | $2.99M | Sell |
1,142,928
-27,051
| -2% | -$70.9K | ﹤0.01% | 2697 |
|
2024
Q4 | $4.82M | Buy |
1,169,979
+231,713
| +25% | +$955K | ﹤0.01% | 2525 |
|
2024
Q3 | $6.64M | Buy |
938,266
+123,854
| +15% | +$877K | ﹤0.01% | 2314 |
|
2024
Q2 | $5.31M | Sell |
814,412
-13,995
| -2% | -$91.2K | ﹤0.01% | 2361 |
|
2024
Q1 | $6.88M | Buy |
828,407
+4,057
| +0.5% | +$33.7K | ﹤0.01% | 2282 |
|
2023
Q4 | $9.08M | Buy |
824,350
+22,992
| +3% | +$253K | ﹤0.01% | 2138 |
|
2023
Q3 | $6.74M | Buy |
801,358
+7,130
| +0.9% | +$60K | ﹤0.01% | 2257 |
|
2023
Q2 | $9.98M | Sell |
794,228
-78,194
| -9% | -$982K | ﹤0.01% | 2065 |
|
2023
Q1 | $14.4M | Sell |
872,422
-9,873
| -1% | -$163K | ﹤0.01% | 1774 |
|
2022
Q4 | $13.2M | Buy |
882,295
+64,460
| +8% | +$963K | ﹤0.01% | 1821 |
|
2022
Q3 | $18.3M | Buy |
817,835
+18,886
| +2% | +$422K | ﹤0.01% | 1545 |
|
2022
Q2 | $13.4M | Buy |
798,949
+148,598
| +23% | +$2.49M | ﹤0.01% | 1806 |
|
2022
Q1 | $19.5M | Sell |
650,351
-34,039
| -5% | -$1.02M | ﹤0.01% | 1699 |
|
2021
Q4 | $21M | Buy |
684,390
+108,462
| +19% | +$3.33M | ﹤0.01% | 1733 |
|
2021
Q3 | $18.2M | Buy |
575,928
+53,822
| +10% | +$1.7M | ﹤0.01% | 1868 |
|
2021
Q2 | $19.1M | Buy |
522,106
+77,973
| +18% | +$2.85M | ﹤0.01% | 1917 |
|
2021
Q1 | $15.4M | Buy |
444,133
+88,240
| +25% | +$3.05M | ﹤0.01% | 2011 |
|
2020
Q4 | $14.8M | Sell |
355,893
-2,165
| -0.6% | -$90K | ﹤0.01% | 2004 |
|
2020
Q3 | $15.2M | Buy |
+358,058
| New | +$15.2M | ﹤0.01% | 1825 |
|